The aim of this study was to investigate the clinical roles of IL-6 signaling components, including IL-6, sIL-6R, sgp130, and their complexes in the plasma of NSCLC patients treated with ICIs. This evidence concerns the gene IL6ST and non-small cell lung carcinoma.